Terumo Value Stock - Dividend - Research Selection
Market price: 4.181,00 JPY
Terumo Corp. Fundamental data and company key figures of the share
|Annual reports in JPY|
|Net operating cash flow||121.485.000.000|
|Free cash flow||59.166.998.528|
|Liabilities & Shareholders equity||1.351.190.000.000|
|Diluted shares outstanding||756.778.000|
✓ NEW Fundamental API Access to 500 data points per month
✓ Fundamental data up to 25 years
✓ Comparison to all other stocks by the FScore
✓ Time saving!
How our site works ...
✓ Non-binding 7 days without automatic subscription
✓ No termination required after the free week
✓ Finanzoo fundamental analysis
✓ Data updated daily
✓ Virtual depots
✓ Share alarms via email
✓ Subscription can be canceled at any time at the end of the month
✓ Choice of desired shares
✓ Over 2000 stock analyzes available
✓ Bitcoin payment possible if you do not want to subscribe
Price for monthly subscription $ 19.99 / month including VAT.
|Market Capitalization||30.505.474.048,00 USD|
|Raw Data Source||IFRS in Millionen JPY|
|Stock Split||2019-03-27,2.0000/1.0000; 2019-03-26,2.0000/1.0000; 2014-03-27,2.0000/1.0000; 2014-03-26,2.0000/1.0000|
Description of the company
TERUMO CORPORATION is manufacturer of medical supplies. The Hospital Products segment is engaged in the manufacture, purchase and sale of hospital medical equipment, pharmaceuticals, peritoneal dialysis and diabetes related products, and the rental of hospital medical equipment and home medical products. The Cardiac and Vascular Area segment is involved in the manufacture, purchase and sale of catheter systems, artificial heart and lungs, as well as artificial blood vessels, the manufacture and sale of therapeutic coils for cerebral aneurysm, sampling equipment and kits for platelet-rich plasma and concentrated bone-marrow cell, and large-bore sheaths. The Blood System segment is engaged in the manufacture, purchase and sale of blood transfusion-related products. It also manufactures and sells healthcare related products. As of March 31, 2013, the Company had 79 subsidiaries and 2 associated companies.